Lupin Pharmaceuticals, Inc. has
received final approval for its Metformin Hydrochloride extended release
tablets (HCL ER) 500 mg and 1000 mg from the United States Food and Drugs
Administration (FDA). According to IMS health data, the total sales of Glumetza
HCL ER tablets, 500 mg and 1000 mg in US, for the twelve months ending March,
2013, was approximately 0731-664-2300
No comments:
Post a Comment